These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 26178761)

  • 21. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
    Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
    Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pragmatic approach to the diagnosis of nodal micrometastases in early stage non-small cell lung cancer.
    Herpel E; Muley T; Schneider T; Palm E; Kieslich de Hol D; Warth A; Meister M; Storz K; Schnabel PA; Schirmacher P; Dienemann H; Hoffmann H
    J Thorac Oncol; 2010 Aug; 5(8):1206-12. PubMed ID: 20581709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Biopathological characteristics of hilar cholangiocarcinoma and the clinical significance].
    Yu WL; Zhang YJ; Dong H; Yu H; Xian ZH; Wu MC; Cong WM
    Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(15):1162-6. PubMed ID: 20021908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma.
    Nakagawa T; Kamiyama T; Kurauchi N; Matsushita M; Nakanishi K; Kamachi H; Kudo T; Todo S
    World J Surg; 2005 Jun; 29(6):728-33. PubMed ID: 15880276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma.
    Ito K; Ito H; Allen PJ; Gonen M; Klimstra D; D'Angelica MI; Fong Y; DeMatteo RP; Brennan MF; Blumgart LH; Jarnagin WR
    Ann Surg; 2010 Apr; 251(4):675-81. PubMed ID: 20224368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancer of zeste homolog 2 (EZH2) promotes progression of cholangiocarcinoma cells by regulating cell cycle and apoptosis.
    Nakagawa S; Okabe H; Sakamoto Y; Hayashi H; Hashimoto D; Yokoyama N; Sakamoto K; Kuroki H; Mima K; Nitta H; Imai K; Chikamoto A; Watanabe M; Beppu T; Baba H
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S667-75. PubMed ID: 23887863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic Significance of the Lymph Node Ratio in Surgical Patients With Distal Cholangiocarcinoma.
    Li X; Lin H; Sun Y; Gong J; Feng H; Tu J
    J Surg Res; 2019 Apr; 236():2-11. PubMed ID: 30694756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Para-aortic lymph node micrometastasis in patients with node-negative biliary cancer.
    Yonemori A; Kondo S; Matsuno Y; Ito T; Tanaka E; Hirano S
    Dig Surg; 2011; 28(4):315-21. PubMed ID: 21921633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma.
    Su MC; Hsu C; Kao HL; Jeng YM
    Cancer Lett; 2006 Apr; 235(1):34-9. PubMed ID: 16125303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significance of lymph node micrometastasis in pN0 hilar bile duct carcinoma.
    Taniguchi K; Tabata M; Iida T; Hori T; Yagi S; Uemoto S
    Eur J Surg Oncol; 2006 Mar; 32(2):208-12. PubMed ID: 16377119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical treatment and prognostic analysis of 93 cases of hilar cholangiocarcinoma.
    Zhang BY; Lu Y; Dong Q; Sun CD; Mu P
    Am J Med Sci; 2010 Mar; 339(3):221-4. PubMed ID: 20220331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
    Ito F; Agni R; Rettammel RJ; Been MJ; Cho CS; Mahvi DM; Rikkers LF; Weber SM
    Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma.
    Kim KH; Lee SG; Park EH; Hwang S; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    Ann Surg Oncol; 2009 Mar; 16(3):623-9. PubMed ID: 19130133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The DNA index as a prognostic tool in hilar cholangiocarcinoma.
    Kamphues C; Al-Abadi N; Bova R; Rademacher S; Al-Abadi H; Klauschen F; Bahra M; Neuhaus P; Pratschke J; Seehofer D
    J Surg Oncol; 2015 Aug; 112(2):214-8. PubMed ID: 26220797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of lymph node ratio after resection of peri-hilar cholangiocarcinoma.
    Guglielmi A; Ruzzenente A; Campagnaro T; Pachera S; Conci S; Valdegamberi A; Sandri M; Iacono C
    HPB (Oxford); 2011 Apr; 13(4):240-5. PubMed ID: 21418129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma.
    Li SQ; Liang LJ; Hua YP; Peng BG; He Q; Lu MD; Chen D
    Chin Med J (Engl); 2009 Oct; 122(19):2286-91. PubMed ID: 20079127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of phosphorylated 4E-binding protein 1 predicts lymph node metastasis and poor prognosis of Chinese patients with hilar cholangiocarcinoma.
    Fang Z; Lu L; Tian Z; Luo K
    Med Oncol; 2014 May; 31(5):940. PubMed ID: 24706262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Impact of Preoperative Lymph Node Enlargement in Intrahepatic Cholangiocarcinoma: A Multi-Institutional Study by the Kyushu Study Group of Liver Surgery.
    Adachi T; Eguchi S; Beppu T; Ueno S; Shiraishi M; Okuda K; Yamashita Y; Kondo K; Nanashima A; Ohta M; Takami Y; Noritomi T; Kitahara K; Fujioka H
    Ann Surg Oncol; 2015 Jul; 22(7):2269-78. PubMed ID: 25582737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma.
    Neuhaus P; Thelen A; Jonas S; Puhl G; Denecke T; Veltzke-Schlieker W; Seehofer D
    Ann Surg Oncol; 2012 May; 19(5):1602-8. PubMed ID: 21964888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
    Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY
    Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.